期刊文献+

HMGB1诱导的小鼠系膜细胞增殖与Akt/NF-κB信号通路激活的相关性 被引量:2

Correlation of HMGB1-induced proliferration of MMC cells and activation of PI3K/Akt signal pathway
下载PDF
导出
摘要 目的探讨Akt/NF-κB信号途径激活在高迁移率族蛋白1(high mobility group protein box 1,HMGB1)诱导小鼠系膜细胞增殖中的作用及意义。方法将常规培养的小鼠系膜细胞随机分为正常对照组和100μg/L HMGB1刺激组;HMGB1刺激+sh-Akt组(质粒转染组)、HMGB1刺激+sh-NC组(空白质粒组)分别培养10 min、20 min、30 min、40 min、50 min、1 h和8 h收集细胞,采用Real-time PCR及Western blot技术检测Akt、p-Akt、PTEN、PCNA、Cyclin D1、CDK4、p16的表达,免疫荧光技术检测BrdU和NF-κB p65蛋白表达。结果 (1)重组的HMGB1能够促进小鼠系膜细胞Akt ser473位点磷酸化和NF-κB核转位;(2)沉默细胞中Akt表达能够显著降低HMGB1诱导的系膜细胞增殖;BrdU阳性率降低;(3)沉默Akt表达显著降低HMGB1诱导的系膜细胞中Cyclin D1、CDK4的表达,上调p16表达;(4)沉默Akt表达能够降低HMGB1诱导的NF-κB核转位,细胞核内NF-κB p65阳性表达降低。结论 PI3K/Akt激活参与HMGB1介导的小鼠系膜细胞增殖,促进NF-κB核转录,激活Cyclin D1/CDK4/p16信号途经可能是其重要的机制之一。 Purpose To explore the effect of Akt/NF-κB signal pathway on cell proliferation of MMC cells induced by HMGB1. Methods MMC was randomly divided into four groups: normal control, HMGB1, HMGB1 plus sh-Akt and HMGB1 plus sh-NC groups. The cells were collected at 10 min, 20 min, 30 min, 40 min, 50 min, 1 h and 8 h, respectively. RNAi method was used to knock down the expression of Akt. qPCR and Western blot were used for the detection of Akt, p-Akt, PTEN, PCNA, cyclinD1, CDK4 and pl6 expression. Immunofluorescent staining was used to detect the BrdU and NF-κB p65 expression. Results ( 1 ) HMGB1 induced Akt phosphorylation and NF-κB p65 nuclei dislocation. (2) Knockdown of Akt expression markedly prevented HMGBl-induced cell proliferation. The positive ratio of BrdU and PCAN expression decreased as compared with HMGBl-treated group. (3) The sh-Akt vector effectively decreased cyclin D1 and CDK4 expression and up-regulated pl6 expression as compared with HMGBl-treated group; (4) Knock-down of Akt downregulated NF-κB p65 nuclei dislocation induced by HMGB1. Conclusion Activation of PI3K/Akt signal pathway could induce NF-κB p65 nuclei dislocation and activate cyclinD1/CDK4/pl6 signal pathway, and thus mediate HMGBI-induced MCC cells proliferation.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第6期641-645,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 教育部新世纪人才支持计划(0300690202) 河北省教育厅(ZH2012002 Z2009151)
关键词 狼疮性肾炎 高迁移率族蛋白1 AKT NF-ΚB 细胞增殖 lupus nephritis high mobility group box 1 Akt NF-κB cell proliferation
  • 相关文献

参考文献16

  • 1Stros M, Polanska E, Struncova S, et al. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase Ⅱ[J]. Nucleic Acide Res, 2009,37(7):2070-86.
  • 2Branchi M E, Beltrame M. Upwardly mobile proteins, workshop: the role of HMG protein in chromatin structure gene expression and neoplasia[J]. EMBO Rep, 2000,1(12):109-14.
  • 3Branchi M E, Beltrame M, Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1[J]. Science, 1989,243(4894 Pt 1):1056-9.
  • 4Feng X, Hao J, Liu Q, et al. HMGB1 mediates IFN-γ-induced cell proliferation in MMC cells through regulation of cyclin D1/CDK4/p16 pathway[J]. J Cell Biochem, 2012,113(6):2009-19.
  • 5Mitchell D, Rodgers K, Hanly J. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells[J]. Am J Pathol, 2004,164(3):937-46.
  • 6Hao J, Zhang Y J, Lv X, et al. IFN-γ induces lipogenesis in mouse mesangial cells via the JAK2/STAT1 pathway[J]. Am J Physiol Cell Physiol, 2013,304(8):c760-7.
  • 7Goldstein R S, Bruchfeld A, Yang L, et al. Cholinergic anti-inflammatory pathway activity and high mobility group Box-1(HMGB1)serum levels in patients with rheumatoid arthritis[J]. Mol Med, 2007,13(3-4):210-5.
  • 8Voll R E, Urbonaviciute V, Herrmann M, et al. High morbility group Box 1 in the pathogenesis of inflammatory and autoimmune disease[J]. Isr Med Assoc J, 2008,10(1):26-8.
  • 9侯晓琳,何春年.磷脂酰肌醇-3-激酶/丝苏氨酸蛋白激酶(PI3K/Akt)信号转导通路与子宫颈癌关系的研究现状[J].临床与实验病理学杂志,2011,27(8):878-881. 被引量:9
  • 10Song G, Ouyang G L, Bao S D. The activation of Akt/PKB signaling pathway and cell survival[J]. Cell Mol Med, 2005,9(1):59-71.

二级参考文献44

  • 1夏曙,于世英.抑制PI3K/Akt提高药物对HeLa细胞放射增敏作用的研究[J].中华放射肿瘤学杂志,2006,15(5):419-422. 被引量:9
  • 2Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statis tics, 2002[J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 3Yuan T L, Cantley L C. PI3K pathway alterations in cancer: vail- ationsons on a theme [ J ]. Oncogene, 2008,27 (41) :5497 - 510.
  • 4Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer [ J ]. Apoptosis, 2004,9 (6) :667 - 76.
  • 5Edwards L A, Thiessen B, Dragowska W H, et al. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt acti- vation, induces apoptosis, and delays tumor growth [ J ]. Oncogene, 2005,24(22) :3596 -605.
  • 6Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival[ J]. J Cell Mol Med, 2005,9 (1) :59 - 71.
  • 7Sharrard R M, Maitland N J. Regulation of protein kinase B activ- ity by PTEN and SHIP2 in human prostate-derived cell lines [ J ]. Cell Signal, 2007,19 ( 1 ) : 129 - 38.
  • 8Gao T, Fumari F, Newton A C. PHLPP: a phosphatase that di- rectly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth[ J] Mol Cell, 2005,18 ( 1 ) : 13 - 24.
  • 9Zhang M, Fang X, Liu H, et al. Bioinformatics-based discovery and characterization of an Akt-selective inhibitor 9-chloro-2-meth- ylellipticinium acetate (CMEP) in breast cancer cells[J]. Cancer Lett, 2007,252 ( 2 ) :244 - 58.
  • 10Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation [ J]. J Biol Chem, 2005,280 (11) :10781 -9.

共引文献13

同被引文献19

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部